9258 Wealth Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$316K Buy
3,772
+128
+4% +$9.77K 0.05% 269
2024
Q2
$250K Sell
3,644
-386
-10% -$25.8K 0.04% 289
2024
Q1
$295K Sell
4,030
-2,340
-37% -$180K 0.05% 272
2023
Q4
$516K Sell
6,370
-44
-0.7% -$3.42K 0.09% 180
2023
Q3
$481K Buy
6,414
+16
+0.3% +$1.23K 0.09% 180
2023
Q2
$493K Sell
6,398
-17
-0.3% -$1.36K 0.09% 185
2023
Q1
$532K Buy
6,415
+17
+0.3% +$1.41K 0.11% 169
2022
Q4
$549K Buy
6,398
+1,417
+28% +$112K 0.12% 162
2022
Q3
$307K Hold
4,981
0.08% 236
2022
Q2
$308K Buy
4,981
+415
+9% +$25.7K 0.08% 243
2022
Q1
$271K Buy
4,566
+1
+0% +$64 0.06% 298
2021
Q4
$332K Buy
4,565
+110
+2% +$7.58K 0.08% 266
2021
Q3
$311K Sell
4,455
-430
-9% -$30.2K 0.08% 252
2021
Q2
$336K Buy
4,885
+522
+12% +$34.9K 0.09% 238
2021
Q1
$282K Sell
4,363
-114
-3% -$7.35K 0.08% 256
2020
Q4
$261K Sell
4,477
-3,273
-42% -$197K 0.09% 253
2020
Q3
$451K Buy
7,750
+304
+4% +$21.1K 0.17% 147
2020
Q2
$573K Sell
7,446
-123
-2% -$9.43K 0.23% 119
2020
Q1
$605K Sell
7,569
-834
-10% -$57.6K 0.27% 105
2019
Q4
$546K Buy
8,403
+1,701
+25% +$111K 0.2% 136
2019
Q3
$425K Buy
6,702
+850
+15% +$55.6K 0.33% 107
2019
Q2
$395K Buy
5,852
+386
+7% +$25.4K 0.32% 108
2019
Q1
$355K Buy
5,466
+1,134
+26% +$75.4K 0.3% 108
2018
Q4
$271K Buy
+4,332
New +$303K 0.26% 120

Other funds holding GILD

9258 Wealth Management's GILD Position: Q3 2024 in Review

9258 Wealth Management increased its Gilead Sciences (GILD) stake by 3.5% in Q3 2024, buying an estimated $9.77K and bringing the position to 3,772 shares worth $316K. The position accounts for 0.05% of the portfolio, ranked #269.

9258 Wealth Management first reported a position in GILD in Q4 2018 and has held it in 24 quarters since. The position peaked at $605K in Q1 2020. 1,718 funds tracked by Wall St. Rank hold GILD as of Q3 2024.

  • 9258 Wealth Management held 3,772 shares of Gilead Sciences worth $316K as of Q3 2024.
  • 9258 Wealth Management bought 128 Gilead Sciences shares in Q3 2024, an estimated $9.77K.
  • Gilead Sciences made up 0.05% of 9258 Wealth Management's portfolio in Q3 2024, its #269 holding.
  • 9258 Wealth Management first reported a position in Gilead Sciences in Q4 2018 and has held it in 24 quarters since.
  • 9258 Wealth Management's Gilead Sciences position peaked at $605K in Q1 2020.
  • 1,718 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2024.

Based on 9258 Wealth Management's 13F filing for Q3 2024, filed 12 Nov 2024.